Decompensation Detection Study
Completed
- Conditions
- Heart Failure
- Registration Number
- NCT00583089
- Lead Sponsor
- Boston Scientific Corporation
- Brief Summary
To gather data and analyze decompensation events.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 699
Inclusion Criteria
- Patients implanted with an approved Guidant CRT-D HF device programmed to CRT therapy in VDD or DDD mode.
- Patients prescribed to the LATITUDE(R) system configured for at least weekly device interrogations and symptoms reporting.
- Patients willing to use the LATITUDE(R) enabled weight scale.
Exclusion Criteria
- Patients that require adaptive rate pacing (rate-responsive modes).
- Patients that have received routinely scheduled intravenous inotropic therapy as part of their drug regimen within the past 90 days.
- Both
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Data collection and analysis. End of patient follow up.
- Secondary Outcome Measures
Name Time Method